Want to join the conversation?
$XRX expects 2Q16 GAAP EPS of $0.06-0.08. Company is aligning its 2016 GAAP EPS and cash flow outlook to reflect separation and restructuring costs. 2016 EPS is expected to be $0.45-0.55 versus previous outlook of $0.66-0.76. $XRX expects cash flow from operations of $0.95-1.20Bil, previously $1.3-1.5Bil, and free cash flow of $600-850MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.